Business Standard

Monday, December 23, 2024 | 12:25 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Everest Kanto, Morepen Lab: 5 stocks to make your portfolio Covid-proof

Major stocks in the healthcare equipment sector are showing firm upside of over 15 per cent

moderna, covid, vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Premium

The current market turmoil, analysts say, can be used as an opportunity to add Covid-related plays to ones portfolio

Avdhut Bagkar Mumbai
The second wave of Covid-19 has hit the economy and the stock market hard with normalcy taking a backseat yet again. At the bourses, portfolio returns have turned negative, with benchmark indices declining over 4 per cent each over the past one month, as investors at large book profit on fears that fresh Covid-19 related restrictions and state-specific lockdowns may pause the economic recovery.

As state governments extend lockdown amid globally record high cases in a single day, analysts fear the earnings of India Inc in the upcoming June quarter may take a hit. 

"Indian economy is on a firm

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in